A vaccine that is FDA-approved to prevent infection with the nine types of human papillomavirus (HPV) that most often cause warts and cancers of the cervix, vagina, vulva, and anus. Recombinant human papillomavirus nonavalent vaccine may also prevent HPV-related cancers of the penis and oropharynx. Recombinant human papillomavirus nonavalent vaccine is approved for use in females and males aged 9 to 45 years. Also called Gardasil 9.